SpicyIP Tidbit – Court’s Friend or Counsel for the Absent Party: Analyzing Delhi Court’s Appointment of Amicus for Vivek Oberoi

/ By / Others

The Delhi High Court’s decision to appoint an amicus curiae to represent Vivek Oberoi’s perspective after his counsel withdrew raises an unusual procedural question in a civil suit pertaining to the right of publicity. This tidbit by Vishwas Kumar Tripathi examines whether such an appointment fits within the established role of an amicus curiae, or risks creating a safety net for plaintiffs who stop actively participating in their own cases. Vishwas is a 4th law student pursuing his B.A. LL.B. […]

SpicyIP Tidbit – Court’s Friend or Counsel for the Absent Party: Analyzing Delhi Court’s Appointment of Amicus for Vivek Oberoi Read More »

SpicyIP Bells & Whistles: IP Events and Opportunities (24.08.2026)

/ By / Courses & Workshops, Opportunities

Welcome back to another week of Bells & Whistles. As always, we’ve rounded up a mix of developments, opportunities, and thoughtful reads from across the IP world along with a Bell of the Week that’s well worth revisiting. Bell of the Week: When Copyright Meets AI – ANI v. OpenAI Some bells mark the beginning of a new chapter. This one may just be the beginning of India’s AI copyright jurisprudence.  This week’s bell goes to ANI Media v. OpenAI, one

SpicyIP Bells & Whistles: IP Events and Opportunities (24.08.2026) Read More »

Image with SpicyIP logo and the words "Weekly Review"

SpicyIP Weekly Review (August 17-August 23)

/ By / Copyright, Patent, Trademark

Starting the week with our weekly roundup of key IP developments and posts on Mavyret patent abandonment, calls for comments on new patent and trademark manuals, and the DHC’s decision in Intra Cellular Therapies v. Controller. This and a lot more in this week’s SpicyIP Weekly Review. Anything we are missing out on? Drop a comment and let us know below. Highlights of the Week Mavyret Patent Abandonment Does Not Open the Field for Hepatitis C Generics Does one patent

SpicyIP Weekly Review (August 17-August 23) Read More »

Mavyret Patent Abandonment Does Not Open the Field for Hepatitis C Generics

/ By / Drug Regulation, Patent

July 28, 2026 marked eight years of the National Viral Hepatitis Control Program (NVHCP). Launched under the National Health Mission, the program aims to eliminate Hepatitis C from India by 2030 through free testing and access to generic versions of direct acting-antivirals (DAAs). One of the most effective drugs for curing patients of Hepatitis C virus (HCV) currently in the market is AbbVie’s Mavyret. It is recognised as the first and only DAA approved to treat both acute and chronic

Mavyret Patent Abandonment Does Not Open the Field for Hepatitis C Generics Read More »

SpicyIP Tidbit: CGPDTM Calls for Comments and Suggestions on New Draft Patent and Trademark Manuals (2026)

/ By / Others, Patent, Trademark

The office of the Controller General of Patents, Designs and Trademarks (CGPDTM) has released two new notifications regarding updates to the office manuals. Yesterday, the office invited comments and suggestions from stakeholders on the Draft Manual of Patent Office (Practice & Procedure), 2026, to be submitted within the next 30 days. Today, the office has invited suggestions on the Draft Manual of Trademark Office (Practice & Procedure), 2026, but within a lesser window of the next 15 days. Comments on the draft manuals

SpicyIP Tidbit: CGPDTM Calls for Comments and Suggestions on New Draft Patent and Trademark Manuals (2026) Read More »

One Atomic Substitution, Two Giant Hurdles of Disclosure and Efficacy

/ By / Patent

In Intra Cellular Therapies v. Controller of Patents, the Delhi High Court revisited two recurring fault lines in pharmaceutical patent law: the coverage disclosure distinction in genus-species claims and the therapeutic efficacy threshold under Section 3(d). Arnav Kaman argues that while the Court gets parts of the Section 3(d) analysis right, its treatment of coverage as disclosure, its failure to meaningfully engage with the applicable novelty standard, and its silence on inventive step leave the judgment doctrinally unclear and the

One Atomic Substitution, Two Giant Hurdles of Disclosure and Efficacy Read More »

Image with SpicyIP logo and the words "Weekly Review"

SpicyIP Weekly Review (August 10- August 16)

/ By / Copyright, Patent, Trademark

Kicking off the week with a roundup of exciting IP developments from August 10 to August 16, in this edition of the SpicyIP Weekly Review. Discussions on the DHC’s decision in Saregama v. Ilaiyaraaja, Guidelines on Section 3(m) examinations by the Delhi High Court, and a post on India’s ISP copyright problem. This and much more in this week’s SpicyIP Weekly Review. Anything we are missing out on? Drop a comment and let us know. Highlight of the Week Playing

SpicyIP Weekly Review (August 10- August 16) Read More »

Three-panel bicycle meme showing “Intermediaries” initially riding smoothly under “Section 79: Stay neutral and retain safe harbour,” then being thrown off balance by “Rule 4(1A), IT Amendment Rules, 2026,” and finally lying on the ground beside the fallen bicycle.

India’s ISP Copyright Problem – Self-Inflicted?

/ By / Copyright

India’s intermediary liability framework has long struggled to reconcile copyright enforcement with the protections afforded to platforms under Section 79 of the IT Act. This tension has recently been amplified by the Delhi High Court’s directions seeking clarity from Meta on its policies governing access to its Rights Manager tool (a development we will examine in one of our forthcoming posts), as well as by the amendments to the IT Rules tightening intermediary obligations (discussed by Sonisha here). Against this

India’s ISP Copyright Problem – Self-Inflicted? Read More »

T-mobile logo with the word "T-mobile" in pink

Playing by Different Rules: Why Equating Section 3(m) to European Patent Law Doesn’t Hold Up

/ By / Patent

[This post is co-authored by Swaraj Barooah and Maneesha Gupta. Maneesha is a fifth-year B.A. LL.B. (Hons.) student at NMIMS School of Law, Bengaluru, and a participant in the SpicyIP Summer School 2026.] A part of the Patents Act that has seen almost no litigation action till last year, has slowly started finding itself in the midst of more and more patent action. Section 3(m) (mere schemes or rules / method of performing of mental act / method of playing

Playing by Different Rules: Why Equating Section 3(m) to European Patent Law Doesn’t Hold Up Read More »

SpicyIP Bells & Whistles: IP Events and Opportunities (11.08.2026)

/ By / Courses & Workshops, Opportunities

Welcome back to another week of Bells & Whistles. As always, we’ve rounded up a mix of developments, opportunities, and thoughtful reads from across the IP world along with a Bell of the Week that’s well worth revisiting. Bell of the Week: oriGIn Some bells are about protecting a product. Others are about giving the communities behind that product a voice. This week’s bell goes to oriGIn (Organization for an International Geographical Indications Network), a global alliance bringing together around 600

SpicyIP Bells & Whistles: IP Events and Opportunities (11.08.2026) Read More »

Scroll to Top